← back to search

Frances R. Levin

Columbia University · US
Area of research
Epidemiology · Psychiatry and Mental health
Research interest
Research focused on Psychiatry and Substance abuse, with related work in Placebo, Cannabis, Attention deficit hyperactivity disorder. Notable publications include 'Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: Results from an international multi-center study exploring DSM-IV and DSM-5...', 'Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients', and 'International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder'.
h-index
citations
1,657
works
17
NIH funding
primary concept
email

Recent publications

Transcranial magnetic stimulation in cocaine use disorder and the risk of seizure: a review of the evidence
Frontiers in Psychiatry 2026cited by 0position: middledoi
Attention‐deficit/hyperactivity disorder (<scp>ADHD</scp>) in adults: evidence base, uncertainties and controversies
World Psychiatry 2025cited by 28position: middledoi
Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials
Nature Medicine 2023cited by 73position: middledoi
COVID‐19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systems
Addiction 2022cited by 19position: middledoi
The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study
BMC Psychiatry 2022cited by 16position: middledoi
The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices
Drug and Alcohol Dependence 2020cited by 149position: middledoi
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda
Drug and Alcohol Dependence 2020cited by 70position: middledoi
International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder
European Addiction Research 2020cited by 50position: middledoi
The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities
European Addiction Research 2020cited by 39position: middledoi
International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder
European Addiction Research 2018cited by 175position: middledoi
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults
Drug and Alcohol Dependence 2017cited by 151position: lastdoi
Vaccine for cocaine dependence: A randomized double-blind placebo-controlled efficacy trial
Drug and Alcohol Dependence 2014cited by 157position: middledoi
Therapeutic infusions of ketamine: Do the psychoactive effects matter?
Drug and Alcohol Dependence 2014cited by 123position: middledoi
Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: Results from an international multi-center study exploring DSM-IV and DSM-5 criteria
Drug and Alcohol Dependence 2013cited by 196position: middledoi
Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients
Drug and Alcohol Dependence 2013cited by 181position: lastdoi
Psychiatric comorbidity in treatment‐seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the <scp>IASP</scp> study
Addiction 2013cited by 164position: middledoi
The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population
International Journal of Methods in Psychiatric Research 2013cited by 66position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Josep Antoni Ramos‐Quiroga · University Hospital Frankfurt3 papers (2013–2025)Johan Franck · Stockholm County Council3 papers (2013–2020)Maija Konstenius · Stockholm Health Care Services3 papers (2013–2020)Geurt van de Glind · Utrecht University3 papers (2013–2020)Wim van den Brink · Amsterdam University Medical Centers3 papers (2013–2020)Kathleen M. Carroll · Yale University2 papers (2017–2020)Ryan G. Vandrey · Johns Hopkins University2 papers (2017–2020)Sharlene Kaye · UNSW Sydney2 papers (2013–2020)Aimee L. McRae‐Clark · San Francisco VA Medical Center2 papers (2017–2020)Arnt Schellekens · Inholland University of Applied Sciences2 papers (2018–2020)Cleo L. Crunelle · University of Antwerp2 papers (2018–2020)Stephen V. Faraone · SUNY Upstate Medical University2 papers (2013–2025)Kevin M. Gray · Medical University of South Carolina2 papers (2017–2020) · 2 papers (2013–2020)Geert Dom · University of Antwerp2 papers (2013–2020)D. Andrew Tompkins · San Francisco General Hospital1 papers (2014–2014) · 1 papers (2020–2020)Larissa J. Mooney · Friends Research Institute1 papers (2017–2017) · 1 papers (2014–2014) · 1 papers (2026–2026)